SCHEMBL29854575

CSCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 7)

	gene	UniProt	supporting neighbours	confidence
▸	NPY2R	P49146	8/20	0.58

▸	NPY4R	P50391	8/20	0.58

▸	NPY5R	Q15761	8/20	0.58

▸	NPY1R	P25929	6/20	0.58

▸	TFPI	P10646	4/20	0.56

▸	CXCL8	P10145	6/20	0.56

▸	CXCR4	P61073	1/20	0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29854740	0.89	NPY2R (0.59)	NPY2RNPY4RNPY5RNPY1RCXCL8
SCHEMBL30842174	0.87	MC4R (0.58)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL29854487	0.86	NPY2R (0.59)	NPY2RNPY4RNPY5RNPY1RCXCL8
SCHEMBL30526200	0.86	BDKRB2 (0.61)	CXCR4
SCHEMBL30567689	0.86	NPY2R (0.65)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL30432435	0.86	NPY2R (0.65)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL29489270	0.85	TFPI (0.58)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL30415378	0.85	TFPI (0.59)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL29854567	0.85	NPY2R (0.68)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL8067075	0.84	NMUR2 (0.58)	NPY2RNPY4RNPY5RNPY1RTFPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20220257719-A1	APPETITE SUPPRESSING COMPOUNDS	IP2IPO INNOVATIONS LIMITED (GB)	2022-08-18	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20220257719-A1	APPETITE SUPPRESSING COMPOUNDS	GIPR, GPR119, IAPP	NPY2R 8/4885NPY4R 6/4885NPY5R 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.